imidazole has been researched along with Cancer of Nasopharynx in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, ML | 1 |
| Lu, YC | 1 |
| Chung, JG | 1 |
| Wang, SG | 1 |
| Lin, HT | 1 |
| Kang, SE | 1 |
| Tang, CH | 1 |
| Ko, JL | 1 |
| Chen, SS | 1 |
1 other study available for imidazole and Cancer of Nasopharynx
| Article | Year |
|---|---|
Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
Topics: Anthraquinones; CDC2 Protein Kinase; Cell Cycle; Cyclin B1; Down-Regulation; Humans; Imidazoles; Mat | 2010 |